No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Patient-led surveillance after treatment of localized melanoma is safe, feasible, and acceptable compared to clinician-led surveillance

MEL-SELF: pilot randomized clinical trial

byKathleen Lau

December 3, 2021

in StudyGraphics

Reading Time: 1 min read

Capecitabine + oxaliplatin chemoradiotherapy does not increase survival, but increases toxicity, compared to capecitabine alone in the postoperative treatment of rectal cancer

RelatedReports

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025

Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

Gastroenterology

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

August 7, 2025

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Chronic Disease

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

August 7, 2025

Gender conformity influences use of laxatives and muscle-building products

Weekly Rewinds

2 Minute Medicine Rewind August 4, 2025

August 4, 2025

Calcium does not significantly improve return of spontaneous circulation in adults with out-of-hospital cardiac arrest

Compliance-linked incentives increase infant immunizations rates in rural India

2 Minute Medicine Rewind December 6, 2021

Large proportion of late preterm infants and older admitted to the NICU

Low socioeconomic status associated with increased body mass index and accelerated growth during infancy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports